durvalumab,pembrolizumab,cisplatin,gemcitabine
merck,astrazeneca
[' gem ']
 agree with keeping gem. but would be interesting to see what percentage of pattients in both arms continued to receive gem as maintenance 
Medical oncologist;
Medicover Cancer Institute, 
Medicover Hospitals.
Founder Precision Cancer Care.
Opinions my own.